Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after breast neoadjuvant chemotherapy.
Rhea ChitaliaMarios MiliotisNariman JahaniSpyros TastsoglouElizabeth S McDonaldVivian BelenkyEric A CohenDavid NewittLaura van 't VeerLaura J EssermanNola M HyltonAngela DeMicheleArtemis HatzigeorgiouDespina KontosPublished in: Communications medicine (2023)
These results demonstrate an important step in combining personalized molecular signatures and longitudinal imaging data towards improved prognosis.